Lars Tanum

Akershus University Hospital

H指数:22

被引数:2,375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study

阿片类药物使用障碍患者中基因对缓释纳曲酮治疗效果的影响：一项探索性研究

Brain Sciences 2026, Vol. 16, Page 23

IF2.8

2025-12-250

OAAI

Changes in Quality of Life During 52 weeks of Extended-Release Naltrexone Treatment, subsequent by a 1-year post-treatment period

52周缓释纳曲酮治疗期间生活质量的变化，随后进入为期1年的治疗后随访期

Drug and Alcohol Dependence

IF3.6

2025-10-100

OAAI

Mortality during and following treatment with extended-release naltrexone based on data from two clinical trials

基于两项临床试验数据，延长释放纳曲酮治疗期间及治疗后的死亡率

Drug and Alcohol Dependence

IF3.6

2025-06-110

Reward Sensitivity in Patients Receiving Opioid Agonist and Antagonist Treatment for Opioid Use Disorder: An Observational Study

阿片类药物使用障碍患者接受阿片类药物激动剂和拮抗剂治疗时的奖赏敏感性：一项观察性研究

biological psychiatry cognitive neuroscience and neuroimaging

IF0

2025-05-080

OAAI

Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial

CLINICAL INFECTIOUS DISEASES

IF7.3

2023-11-2210

OAAI

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone

HELIYON

IF3.6

2023-07-010

OAAI

Patients' experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study

患者持续使用缓释纳曲酮治疗的经验: 挪威定性研究

clinical psychology science and practice

IF3.2

2022-07-183

OAAI

'Not at all what I had expected': Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study

“完全不是我所期望的”: 停止使用缓释纳曲酮 (xr-ntx) 治疗: 一项定性研究

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2022-05-0112

OAAI

Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2022-04-012

OAAI

Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-09-308

OAAI

Adapting treatment length to opioid-dependent individuals' needs and preferences: a 2-year follow-up to a 1-year study of extended-release naltrexone

ADDICTION

IF5.3

2021-01-209

OAAI

No Increase in Chronic Pain Among Opioid-Dependent Individuals Randomized to Treatment With Extended-Release Naltrexone Compared to Buprenorphine-Naloxone

BIOLOGICAL PSYCHIATRY

IF9

2019-05-011

PREAI

Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial

ADDICTION

IF5.3

2018-06-2227

OAAI

The Effectiveness of Injectable Extended Release Naltrexone Versus Daily Buprenorphine-Naloxone for Opioid Dependence in Short and Long Term Treatment

BIOLOGICAL PSYCHIATRY

IF9

2018-05-014

PREAI

Evidence of both Systemic Inflammation and Neuroinflammation in Patients with Chronic Widespread Pain

BIOLOGICAL PSYCHIATRY

IF9

2017-05-010

PREAI

Optimal prevention of relapse among opioid users: A 12-week randomized controlled trial of extended-release naltrexone injections versus daily buprenorphine-naloxone

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2017-02-011

PREAI

Antidepressants have Anti-inflammatory Effects that may be Relevant to Dermatology: A Systematic Review

抗抑郁药具有抗炎作用，可能与皮肤病学有关: 系统综述

ACTA DERMATO-VENEREOLOGICA

IF3.7

2017-01-0131

OAAI

Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram

CLINICAL AND EXPERIMENTAL DERMATOLOGY

IF2.8

2016-04-024

PREAI

Speed of recovery from disorientation may predict the treatment outcome of electroconvulsive therapy (ECT) in elderly patients with major depression

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2016-01-0115

OAAI

Baseline cognitive function does not predict the treatment outcome of electroconvulsive therapy (ECT) in late-life depression

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2015-10-0110

OAAI

Lars Tanum

个人简介

教育背景

工作经历

荣誉奖项

研究方向